CALA

Calithera Biosciences (CALA)

Calithera Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CALA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/30	05 : 01	GlobeNewswire Inc.	Calithera Biosciences Announces Update on Complete Liquidation and Dissolution	NASDAQ:CALA	Calithera Biosciences Inc
2023/06/15	22 : 14	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:CALA	Calithera Biosciences Inc
2023/06/06	06 : 17	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (definitive) (defm14a)	NASDAQ:CALA	Calithera Biosciences Inc
2023/05/27	05 : 29	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (preliminary) (prem14a)	NASDAQ:CALA	Calithera Biosciences Inc
2023/05/26	20 : 09	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:CALA	Calithera Biosciences Inc
2023/05/26	20 : 09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CALA	Calithera Biosciences Inc
2023/05/22	19 : 01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CALA	Calithera Biosciences Inc
2023/05/20	05 : 01	GlobeNewswire Inc.	Calithera Biosciences Announces Update on Complete Liquidation and Dissolution	NASDAQ:CALA	Calithera Biosciences Inc
2023/03/31	19 : 02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CALA	Calithera Biosciences Inc
2023/03/15	05 : 16	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:CALA	Calithera Biosciences Inc
2023/03/15	05 : 13	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CALA	Calithera Biosciences Inc
2023/03/15	05 : 10	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CALA	Calithera Biosciences Inc
2023/03/15	05 : 09	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CALA	Calithera Biosciences Inc
2023/03/15	05 : 08	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CALA	Calithera Biosciences Inc
2023/03/15	05 : 07	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CALA	Calithera Biosciences Inc
2023/03/15	05 : 05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CALA	Calithera Biosciences Inc
2023/03/15	05 : 03	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CALA	Calithera Biosciences Inc
2023/03/04	00 : 46	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:CALA	Calithera Biosciences Inc
2023/02/15	01 : 49	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CALA	Calithera Biosciences Inc
2023/02/14	22 : 04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CALA	Calithera Biosciences Inc
2023/02/10	06 : 02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CALA	Calithera Biosciences Inc
2023/02/09	06 : 06	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CALA	Calithera Biosciences Inc
2023/01/26	06 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CALA	Calithera Biosciences Inc
2023/01/26	06 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CALA	Calithera Biosciences Inc
2023/01/26	06 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CALA	Calithera Biosciences Inc
2023/01/26	06 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CALA	Calithera Biosciences Inc
2023/01/26	06 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CALA	Calithera Biosciences Inc
2023/01/09	22 : 08	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CALA	Calithera Biosciences Inc
2023/01/09	22 : 00	GlobeNewswire Inc.	Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolution	NASDAQ:CALA	Calithera Biosciences Inc
2022/12/09	01 : 50	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CALA	Calithera Biosciences Inc